Keywords: akzo, nobel, net, up, sales, growth, dutch
Akzo Nobel net up 22% on 6% sales growth
Article | 25 July 2005
Dutch drugs and chemicals group Akzo Nobel reported a 22% rise to 182.0 million euros ($219.4 million) in second-quarter 2005 net income, with earnings ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
